These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 16791717)

  • 41. Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.
    Derosa G; Cicero AF; D'Angelo A; Gaddi A; Ciccarelli L; Piccinni MN; Salvadeo SA; Pricolo F; Ferrari I; Gravina A; Ragonesi PD
    Clin Ther; 2006 May; 28(5):679-88. PubMed ID: 16861090
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Degree of control and delayed intensification of antihyperglycaemic treatment in type 2 diabetes mellitus patients in primary care in Spain.
    Conthe P; Mata M; Orozco D; Pajuelo F; Barreto CS; Anaya SF; Gomis R
    Diabetes Res Clin Pract; 2011 Jan; 91(1):108-14. PubMed ID: 21035225
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects.
    Bays HE; Goldberg RB; Truitt KE; Jones MR
    Arch Intern Med; 2008 Oct; 168(18):1975-83. PubMed ID: 18852398
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Short and long-term outcomes from a multisession diabetes education program targeting low-income minority patients: a six-month follow up.
    Ryan JG; Jennings T; Vittoria I; Fedders M
    Clin Ther; 2013 Jan; 35(1):A43-53. PubMed ID: 23328276
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Insulin glargine benefits patients with type 2 diabetes inadequately controlled on oral antidiabetic treatment: an observational study of everyday practice in 12,216 patients.
    Schreiber SA; Haak T
    Diabetes Obes Metab; 2007 Jan; 9(1):31-8. PubMed ID: 17199716
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of Mobile Text Messaging on Glycemic Control in Patients With Coronary Heart Disease and Diabetes Mellitus: A Randomized Clinical Trial.
    Huo X; Krumholz HM; Bai X; Spatz ES; Ding Q; Horak P; Zhao W; Gong Q; Zhang H; Yan X; Sun Y; Liu J; Wu X; Guan W; Wang X; Li J; Li X; Spertus JA; Masoudi FA; Zheng X
    Circ Cardiovasc Qual Outcomes; 2019 Sep; 12(9):e005805. PubMed ID: 31474119
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Medication Management Program: Adherence, Disease-related Knowledge, Health-related Quality of Life, and Glycemic Control for Type 2 Diabetes Mellitus.
    Nazir SUR; Hassali MA; Saleem F; Haque N
    Altern Ther Health Med; 2020 Jul; 26(S2):4-10. PubMed ID: 31634877
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Optimal type 2 diabetes mellitus management: the randomised controlled OPTIMISE benchmarking study: baseline results from six European countries.
    Hermans MP; Brotons C; Elisaf M; Michel G; Muls E; Nobels F;
    Eur J Prev Cardiol; 2013 Dec; 20(6):1095-105. PubMed ID: 22605788
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Metabolic control and weight loss in patients with obesity and type 2 diabetes mellitus, treated with exenatide].
    Pujante Alarcón P; Hellín Gil MD; Román LM; Ferrer Gómez M; García Zafra MV; Tébar Massó J
    Med Clin (Barc); 2012 Dec; 139(13):572-8. PubMed ID: 22209597
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of a 36-month pharmaceutical care program on the coronary heart disease risk in elderly diabetic and hypertensive patients.
    Neto PR; Marusic S; de Lyra Júnior DP; Pilger D; Cruciol-Souza JM; Gaeti WP; Cuman RK
    J Pharm Pharm Sci; 2011; 14(2):249-63. PubMed ID: 21733413
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of an Academic-Community Partnership to Implement MTM Services in Rural Communities to Improve Pharmaceutical Care for Patients with Diabetes and/or Hypertension.
    Johnson M; Jastrzab R; Tate J; Johnson K; Hall-Lipsy E; Martin R; Taylor AM; Warholak T
    J Manag Care Spec Pharm; 2018 Feb; 24(2):132-141. PubMed ID: 29384026
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Peer-led diabetes education programs in high-risk Mexican Americans improve glycemic control compared with standard approaches: a Project Dulce promotora randomized trial.
    Philis-Tsimikas A; Fortmann A; Lleva-Ocana L; Walker C; Gallo LC
    Diabetes Care; 2011 Sep; 34(9):1926-31. PubMed ID: 21775748
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter, observational study.
    Kawamori R; Node K; Hanafusa T; Atsumi Y; Naito Y; Oka Y
    Cardiovasc Diabetol; 2013 Sep; 12():131. PubMed ID: 24011395
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of dulaglutide on vascular health indexes in subjects with type 2 diabetes: a randomized trial.
    Tuttolomondo A; Cirrincione A; Casuccio A; Del Cuore A; Daidone M; Di Chiara T; Di Raimondo D; Corte VD; Maida C; Simonetta I; Scaglione S; Pinto A
    Cardiovasc Diabetol; 2021 Jan; 20(1):1. PubMed ID: 33397395
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The short-term effect of a switch from glibenclamide to metformin on blood pressure and microalbuminuria in patients with type 2 diabetes mellitus.
    Amador-Licona N; Guízar-Mendoza J; Vargas E; Sánchez-Camargo G; Zamora-Mata L
    Arch Med Res; 2000; 31(6):571-5. PubMed ID: 11257323
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: U.K. Prospective Diabetes Study (UKPDS 55).
    Davis TM; Cull CA; Holman RR;
    Diabetes Care; 2001 Jul; 24(7):1167-74. PubMed ID: 11423497
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The long-term efficacy of insulin glargine plus oral antidiabetic agents in a 32-month observational study of everyday clinical practice.
    Schreiber SA; Ferlinz K; Haak T
    Diabetes Technol Ther; 2008 Apr; 10(2):121-7. PubMed ID: 18260775
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.
    Ushakova O; Sokolovskaya V; Morozova A; Valeeva F; Zanozina O; Sazonova O; Zhadanova E; Starceva M; Kazakova E; Saifullina M; Shapiro I; Tarasov A; Al-Tayar B; Starkova N
    Clin Ther; 2007 Nov; 29(11):2374-84. PubMed ID: 18158078
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy.
    Malone JK; Kerr LF; Campaigne BN; Sachson RA; Holcombe JH;
    Clin Ther; 2004 Dec; 26(12):2034-44. PubMed ID: 15823767
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diabetes Medication Assistance Service Stage 1: impact and sustainability of glycaemic and lipids control in patients with Type 2 diabetes.
    Krass I; Mitchell B; Song YJ; Stewart K; Peterson G; Hughes J; Smith L; White L; Armour C
    Diabet Med; 2011 Aug; 28(8):987-93. PubMed ID: 21418096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.